Results 161 to 170 of about 3,234 (194)

Rapporto costo-efficacia della terapia peginterferone α-2a + ribavirina in confronto a interferone α-2b + ribavirina in pazienti affetti da epatite cronica di tipo C precedentemente non trattati

PharmacoEconomics Italian Research Articles, 2004
Introduction In adults with previously untreated chronic hepatitis C (CHC), the combination of peginterferon α-2a plus ribavirin produces a higher rate of sustained virological response (SVR) than interferon α-2b plus ribavirin, but it is still unproven whether this increase is cost-effective.
Sean D. Sullivan, A. Craxì, A. Alberti, G. Giuliani, C. De Carli, N. Wintfeld, K. K. Patel, J. Green   +7 more
openaire   +1 more source

Costo efficacia di peginterferone α-2a + ribavirina versus peginterferone α-2b + ribavirina nel trattamento dell’epatite cronica di tipo C in pazienti HIV co-infetti

PharmacoEconomics Italian Research Articles, 2008
Introduction: The objective of this study was to evaluate the cost-effectiveness of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin in the treatment of chronic hepatitis C in HIV-HCV co-infection. Methods: We used a pre-existent Markov model of disease progression in which two cohorts of patients received ...
openaire   +1 more source

Hepatitis C aguda: respuesta al tratamiento combinado con interferón alfa más ribavirina

Gastroenterología y Hepatología, 2002
Introduccion La hepatitis C es una de las causas mas frecuentes de enfermedad hepatica cronica en nuestro medio. La mayoria de los pacientes que presentan una infeccion aguda por el virus de la hepatitis C (VHC) desarrollan hepatitis cronica, y solo entre un 15 y un 30% se resuelven espontaneamente.
R. Vega Palomares, R. Planas Vilà, R. Durández Lazaro, S. Fábregas Puigtió   +3 more
openaire   +1 more source

Perspectivas futuras del tratamiento de la hepatitis C, ¿sin interferón y sin ribavirina?

Gastroenterología y Hepatología, 2014
Resumen La infeccion por el virus de la hepatitis C supone un problema de salud relevante a nivel mundial. Actualmente, el tratamiento estandar en la hepatitis cronica C genotipo 1 consiste en la combinacion de interferon pegilado, ribavirina y un inhibidor de proteasa de primera generacion: telaprevir o boceprevir. No obstante, a pesar de la mejoria
Sabela Lens, Ignacio Alfaro
openaire   +1 more source

Peginterferone α-2a pié ribavirina versus peginterferone α-2b pié ribavirina: un confronto di efficacia clinica e di costo nel trattamento di pazienti naïve affetti da epatite cronica di tipo C

Giornale Italiano di Health Technology Assessment, 2011
Background and aims The goal of this study was to estimate the incremental efficacy and incremental cost of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin in treatment-naive patients with chronic hepatitis C.
R. Ravasio, A. Ascione
openaire   +1 more source

Ribavirina/Molnupiravir (antivirales) síntesis introducción

2023
La Parra, Mario González-De, Torres, Hector   +1 more
openaire   +1 more source

Efeitos da Ribavirina (Virazole) a ultrastrutura nuclear em células CV1

1981
Ribavirin (Virazole) lias been studied like antiviral, but it is not yeat clear whether the compound is specfflcally antiviral in its mode of action or whetlier It inhibits virus replication as a result of its effect(s) on the host cell. The effects on cellular metabolism are not well known we dont’t know any work about the effects of Ribavirin on the ...
Valdeira, Maria Luísa, Matos, A. P. Alves de   +1 more
openaire   +1 more source

Ribavirina (antiviral vs hepatitis C) síntesis

2023
Torres, Hector, La Parra, Mario González-De   +1 more
openaire   +1 more source

Ribavirina (antiviral vs hepatitis C) análisis retrosintético

2023
Torres, Hector, La Parra, Mario González-De   +1 more
openaire   +1 more source

Ribavirina

2022
openaire   +1 more source